Provided by Tiger Trade Technology Pte. Ltd.

10x Genomics, Inc.

80.65
+3.374.36%
Post-market: 81.050.4000+0.50%19:54 EDT
Volume:3.69M
Turnover:301.42M
Market Cap:10.51B
PE:-137.07
High:85.12
Open:78.60
Low:78.52
Close:77.28
52wk High:102.81
52wk Low:11.16
Shares:130.29M
Float Shares:118.00M
Volume Ratio:0.61
T/O Rate:3.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5884
EPS(LYR):-0.3490
ROE:-9.40%
ROA:-5.05%
PB:12.73
PE(LYR):-231.06

Loading ...

Why Did 10x Genomics (TXG) Stock Climb Today?

Simply Wall St.
·
6 hours ago

Movement Alert|10x Genomics, Inc. Rises 6.25% in Regular Trading on BofA Securities Target Price Hike

Market Focus
·
Yesterday

BofA Securities Adjusts 10x Genomics Price Target to $80 From $50

MT Newswires Live
·
Yesterday

Movement Alert|10x Genomics, Inc. Declines 5.26% in Regular Trading, Fred Hutchinson Collaboration Fails to Lift Market Confidence

Market Focus
·
Oct 08

Movement Alert|10x Genomics Falls 5.15% in Pre-Market Trading, Fred Hutchinson Collaboration Fails to Lift Sentiment

Market Focus
·
Oct 08

Movement Alert|10x Genomics Falls 6.72% in Regular Trading, Life Sciences Tools Sector Weak in Broad Selloff

Market Focus
·
Oct 07

10x Genomics, Fred Hutch Launch Clinical Research Collaboration on Single-Cell, Spatial Oncology Applications

Reuters
·
Oct 07

10x Genomics Announces New Collaboration to Advance Single Cell and Spatial Applications Across Solid Tumors and Blood Cancers

THOMSON REUTERS
·
Oct 07

Barclays Reaffirms Their Buy Rating on 10x Genomics (TXG)

TIPRANKS
·
Oct 07

10x Genomics falls -13.4%

TIPRANKS
·
Oct 07

Movement Alert | 10x Genomics, Inc. Falls 6.13% in Regular Trading, Sector-Wide Weakness Weighs on Tech Platform Stocks

Market Focus
·
Oct 06

Movement Alert|10x Genomics, Inc. Intraday Rise 5.06%, Atera Commercial Shipments Launched Amid Positive Analyst Rating

Market Focus
·
Oct 06

10x Genomics (TXG) Could Be 50% Above Fair Value On Sentira And Atera Launches

Simply Wall St.
·
Oct 03

Movement Alert|10x Genomics, Inc. Rises 5.55% in Regular Trading, Atera Platform Begins Commercial Shipments as Analyst Initiates with Buy Rating

Market Focus
·
Oct 02

Novartis Bets $7.8 Billion On MRNA Beyond Vaccines

Options & Short Sell
·
Oct 02

From Exoskeletons to AI: ChronoScale's Billion-Dollar Pivot

Tech News Roundup
·
Oct 02

10x Genomics Price Target Raised to $90.00/Share from $40.00 by Leerink Partners

Dow Jones
·
Sep 30

10x Genomics Begins Commercial Shipments of Atera

MT Newswires Live
·
Sep 29

10x Genomics price target raised to $90 from $40 at Leerink

TIPRANKS
·
Sep 29

Leerink Partners Sticks to Its Hold Rating for 10x Genomics (TXG)

TIPRANKS
·
Sep 29